基于随机化的MCP-Mod推断
该文针对MCP-Mod方法在小样本二分类终点中因完全分离导致估计不存在的问题,引入惩罚最大似然估计与基于随机化的推断,模拟显示基于残差的随机化检验可提高中小样本统计功效并控制I类错误率。
要点
- 惩罚最大似然估计可解决MCP-Mod中小样本二分类终点的完全分离问题。
- 基于随机化的检验在中小样本中提高统计功效,并控制I类错误率。
- 基于残差的随机化检验计算效率更高且优于标准随机化方法。
核心结论
- 基于随机化的推断在小样本剂量探索试验分析中具有潜力,基于残差的随机化检验使用惩罚最大似然估计是MCP-Mod框架下剂量探索分析的合适选择。
研究设计与样本
- 方法学研究,受实际临床试验使用MCP-Mod方法启发,引入惩罚最大似然估计和基于随机化的推断技术,并通过模拟研究评估。
主要发现
- 模拟研究表明,基于随机化的检验在中小样本中可提高统计功效,同时控制I类错误率,即使存在时间趋势。
- 基于残差的随机化检验使用惩罚最大似然估计不仅提高计算效率,而且优于标准随机化方法。
- 将这些方法应用于药物计量学场景,展示了其有效性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dose selection is critical in pharmaceutical drug development, as it directly impacts therapeutic efficacy and patient's safety of a drug. The Generalized Multiple Comparison Procedures and Modeling approach is commonly used in Phase II trials for testing and estimation of dose-response relationships. However, its effectiveness in small sample sizes, particularly with binary endpoints, is hindered by issues like complete separation in logistic regression, leading to non existence of estimates. Motivated by an actual clinical trial using the MCP-Mod approach, this paper introduces penalized maximum likelihood estimation (MLE) and randomization-based inference techniques to address these challenges. Randomization-based inference allows for exact finite sample inference, while population-based inference for MCP-Mod typically relies on asymptotic approximations. Simulation studies demonstrate that randomization-based tests can enhance statistical power in small to medium-sized samples while maintaining control over type-I error rates, even in the presence of time trends. Our results show that residual-based randomization tests using penalized MLEs not only improve computational efficiency but also outperform standard randomization-based methods, making them an adequate choice for dose-finding analyses within the MCP-Mod framework. Additionally, we apply these methods to pharmacometric settings, demonstrating their effectiveness in such scenarios. The results in this paper underscore the potential of randomization-based inference for the analysis of dose-finding trials, particularly in small sample contexts.
引用
- Pin L, Sverdlov O, Bretz F, et al. Randomization-Based Inference for MCP-Mod. Stat Med. 2025. PMID: 40402128. doi:10.1002/sim.70092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。